# HealthQuad

> HealthQuad is a VC fund in Mehrauli backing Health Care and Medical. See 40 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Mehrauli, India
- Total investments: 40
- Last investment: May 2026
- Lead investor: 50%
- Fund size: $162M
- Last fund: Mar 2022
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company-beta/13188301/
- X (Twitter): https://twitter.com/healthquad
- Website: http://healthquad.in

HealthQuad is a VC fund in Mehrauli focused on Health Care and Medical. HealthQuad’s investment philosophy is to create value by empowering visionary entrepreneurs building unique solutions that have the potential to redefine the way the society prevents and treats illness. Their approach is defined by “inspired ownership” and they strive to act as a meaningful strategic partner and not just as a financial sponsor.They provide a platform where entrepreneurs can work with us to get not only the capital but also the advice, support, and tools they need to achieve their market potential. In the eyes of the entrepreneurs, they see that the breadth and depth of their expertise, their strong network and their rich ecosystem, are their raison d’être for partnering with us.

## Contacts

5 contacts available for HealthQuad. Shizune tracks 7 team members at HealthQuad. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/healthquads?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $5M–$20M |
| Series B | $15M–$33M |
| Series C | $40M–$75M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 18 | 45% |
| Medical | 5 | 13% |
| Wellness | 5 | 13% |
| Hospital | 4 | 10% |
| Software | 4 | 10% |

33 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 8 | 20% |
| Series A | 6 | 15% |
| Series C | 5 | 13% |
| Funding Round | 5 | 13% |
| Series D | 3 | 8% |

8 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ajay Mahipal | Director | 6 | https://shizune.co/investors/profile/ajay-mahipal |
| Abrar Mir | Co-Founder & Advisor | 3 | https://shizune.co/investors/profile/abrar-mir |
| Amit Varma | Co-Founder & Advisor | 0 | https://shizune.co/investors/profile/amit-varma-4773 |
| Charles-Antoine Janssen | Co-Founder and Chief Investment Officer | 6 | https://shizune.co/investors/profile/charles-antoine-janssen-92f4 |
| Charles-Antoine Janssen | Co-Founder and Chief Investment Officer | 5 | https://shizune.co/investors/profile/charles-janssen |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| LifeSigns | Lifesigns is a healthcare company that offers real-time patient monitoring solutions. |  | Venture - Series Unknown | May 11, 2026 |  |
| ekincare | ekincare is a patent-pending AI-powered integrated health benefits platform helping organizations and Employees with a Preventive, Predictive and Highly Personalised Healthcare solution.Trusted by many fortune 500 companies ekincare redefines healthcare by being India's first personal health assistant using technology, analytics, andcurated services.Our integrated platform provides access to a multitude of online and offline healthcare services such as 24*7 chat with a doc, health check-ups, medicines purchase and delivery, Health coach programs, Mental wellness programs, Gyms & Fitness services, etc |  | Series C | Apr 29, 2025 |  |
| Beta Drugs | Beta Drugs is a drug delivery system that differentiates itself and increases patient compliance. They promote patient compliance, are simple to use, prevent dosing mistakes, and reduce drug waste. They create and market sophisticated oncology medications. | $13.9M | Post-IPO Equity | Nov 28, 2024 |  |
| Redcliffe Labs | Redcliffe LifetechRedcliffe Lifesciences specializes in reproductive health testing, rare diseases, and cancer genetic diagnostics. The company offers a wide range of advanced products and services for healthcare companies, research institutions, and other public and private partnerships, such as testing using molecular and gene-based diagnostics,therapeutic molecules and advanced therapies, next-generation sequencing, and all bioinformatics services. | $42M | Series C | Sep 17, 2024 |  |
| Qure AI | At Qure.ai their mission is to make healthcare affordable and accessible using the power of artificial intelligence. They build deep learning solutions that aid physicians with routine diagnosis and treatment, allowing them to spend more time with patients. | $65M | Series D | Jun 25, 2024 |  |
| RED.Health | Stanplus Provides 24/7 emergency and medical transportation support.Their fleet 180+ Ambulances can support patients in 15 minutes across Hydrabad, eqquiped with ALS, BLS, Cardiac and Paitent transport Ambulance. | $20M | Series B | Apr 02, 2024 |  |
| CureSkin | CureSkin is a mobile application for derma-care. It is uses computer vision to recommend treatment to patients who don’t have access to trained professionals. | $20M | Series B | Mar 13, 2024 |  |
| CureSkin | CureSkin is a mobile application for derma-care. It is uses computer vision to recommend treatment to patients who don’t have access to trained professionals. | $20M | Series B | Mar 13, 2024 |  |
| CureSkin | CureSkin is a mobile application for derma-care. It is uses computer vision to recommend treatment to patients who don’t have access to trained professionals. | $20M | Series B | Mar 13, 2024 |  |
| GoApptiv | GoApptiv offers end-to-end go-to-market solutions to pharmaceutical companies in India. Our proprietary data analytics tools combined with a network of distribution partners allows us to access these markets in the most cost effective and efficient way possible. HeathTech \| Data Analytics \| Phygital |  | Series B | Jan 31, 2024 |  |

10 of 40 investments shown.

## Co-investors
- [Novo Holdings](https://shizune.co/investors/profile/novo-a-s) — VC Fund, 6 deals together
- [British International Investment](https://shizune.co/investors/profile/cdc-group) — VC Fund, 5 deals together
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 5 deals together
- [HealthXCapital](https://shizune.co/investors/profile/healthxcapital) — VC Fund, 4 deals together
- [JSW Ventures](https://shizune.co/investors/profile/jsw-ventures) — VC Fund, 4 deals together
- [Kalaari Capital](https://shizune.co/investors/profile/kalaari-capital) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in India](https://shizune.co/investors/health-care-vc-funds-india)
- [Health Care Investors in India](https://shizune.co/investors/health-care-investors-india)
- [Medical Investors in India](https://shizune.co/investors/medical-investors-india)
- [Medical VC Funds in India](https://shizune.co/investors/medical-vc-funds-india)
- [Medical Device Investors in India](https://shizune.co/investors/medical-device-investors-india)
- [Medical Device VC Funds in India](https://shizune.co/investors/medical-device-vc-funds-india)

## FAQ

### What does HealthQuad invest in?

HealthQuad invests primarily in Health Care, Medical and Wellness startups, most often at Series B and Series A stage. Most of the 40 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is HealthQuad's check size?

HealthQuad typically joins rounds of $5M–$20M at Series A, $15M–$33M at Series B and $40M–$75M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds HealthQuad participates in.

### How do I contact HealthQuad?

Public channels for HealthQuad include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at HealthQuad?

The team at HealthQuad includes Ajay Mahipal (Director), Abrar Mir (Co-Founder & Advisor) and Amit Varma (Co-Founder & Advisor), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co